Temple University has been selected to continue as a clinical hub for the National Institutes of Health (NIH) Strategies to Innovate EmeRgENcy Care Clinical Trials Network, or SIREN. SIREN supports the rapid implementation of high-quality, large-scale clinical trials in emergency medicine and supports clinical trials aimed at improving patient outcomes for neurologic, heart, lung, blood and traumatic emergencies. Temple has served as a SIREN clinical hub since 2017. The Temple-SIREN clinical hub coordinates the efforts of a large group of academic medical centers and emergency medical systems throughout the metro Philadelphia area and across Pennsylvania and New Jersey.
“Temple is proud to be selected by the NIH to continue as a clinical hub for this innovative clinical trial network,” said Nina Gentile, MD, Professor of Emergency Medicine and Research Director in the Department of Emergency Medicine at the Lewis Katz School of Medicine at Temple University and Principal Investigator of the Temple-SIREN clinical hub. “Temple University Hospital is a leading site for emergency care clinical trials and we will now have the opportunity to build on our highly successful infrastructure. Our group has been working together since we were first named a SIREN clinical hub in 2017, substantially contributing to advances in science and treatment of patients with illness and injury.”
SIREN consists of a Clinical Coordinating Center at the University of Michigan, a Data Coordinating Center at the Medical University of South Carolina, and 15 clinical centers (Hubs) across the country that will coordinate and conduct clinical trials in both emergency department treatment and pre-hospital settings (such as in the ambulance). These trials cover all areas of emergency research from the most critical, such as heart attack and traumatic brain injury, to chronic conditions such as asthma and migraine headache, that frequently lead people to emergency departments.
For more details on SIREN, please visit: siren.network.